Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
BMC Health Services Research
|
December 31, 2009
Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada
Mark Oremus, Jean-Eric Tarride, Natasha Clayton, et al.
Health and Quality of Life Outcomes
|
July 20, 2016
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers
Mingying Fang, Mark Oremus, Jean-Eric Tarride, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement
|
July 7, 2007
Physicians' efficacy requirements for prescribing medications to persons with Alzheimer's disease
Mark Oremus, Christina Wolfson, Howard Bergman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 21, 2014
Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights
Mark Oremus, Jean-Eric Tarride, Natasha Clayton, et al.
International Journal of Geriatric Psychiatry
|
March 26, 2019
Intermittent antipsychotic medication and mortality in institutionalized older adults: A scoping review
Jason M Randle, George Heckman, Mark Oremus, et al.
Health and Quality of Life Outcomes
|
September 7, 2025
A reinvigorated Health and Quality of Life Outcomes: recent successes and renewed aims & scope
Mark Oremus, Brendan Mulhern, Oliver Rivero-Arias, et al.
BMJ Open
|
November 4, 2021
Association of chiropractic integration in an Ontario community health centre with prescription opioid use for chronic non-cancer pain: a mixed methods study protocol
Peter C Emary, Mark Oremus, Lawrence Mbuagbaw, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition
|
January 28, 2022
Subtypes of social support availability are not differentially associated with memory: a cross-sectional analysis of the Comprehensive Cohort of the Canadian Longitudinal Study on Aging
Avery Ohman, Colleen J Maxwell, Suzanne L Tyas, et al.
International Journal of Technology Assessment in Health Care
|
April 30, 2014
Ethics expertise for health technology assessment: a Canadian national survey
Kenneth Bond, Mark Oremus, Katherine M Duthie, et al.
Pharmacoepidemiology and Drug Safety
|
January 7, 2003
A survey of physician efficacy requirements to plan clinical trials
Mark Oremus, Jean-Paul Collet, Jacques Corcos, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
BMC Health Services Research
|
December 31, 2009
Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada
Mark Oremus, Jean-Eric Tarride, Natasha Clayton, et al.
Health and Quality of Life Outcomes
|
July 20, 2016
A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers
Mingying Fang, Mark Oremus, Jean-Eric Tarride, et al.
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement
|
July 7, 2007
Physicians' efficacy requirements for prescribing medications to persons with Alzheimer's disease
Mark Oremus, Christina Wolfson, Howard Bergman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 21, 2014
Health utility scores in Alzheimer's disease: differences based on calculation with American and Canadian preference weights
Mark Oremus, Jean-Eric Tarride, Natasha Clayton, et al.
International Journal of Geriatric Psychiatry
|
March 26, 2019
Intermittent antipsychotic medication and mortality in institutionalized older adults: A scoping review
Jason M Randle, George Heckman, Mark Oremus, et al.
Health and Quality of Life Outcomes
|
September 7, 2025
A reinvigorated Health and Quality of Life Outcomes: recent successes and renewed aims & scope
Mark Oremus, Brendan Mulhern, Oliver Rivero-Arias, et al.
BMJ Open
|
November 4, 2021
Association of chiropractic integration in an Ontario community health centre with prescription opioid use for chronic non-cancer pain: a mixed methods study protocol
Peter C Emary, Mark Oremus, Lawrence Mbuagbaw, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition
|
January 28, 2022
Subtypes of social support availability are not differentially associated with memory: a cross-sectional analysis of the Comprehensive Cohort of the Canadian Longitudinal Study on Aging
Avery Ohman, Colleen J Maxwell, Suzanne L Tyas, et al.
International Journal of Technology Assessment in Health Care
|
April 30, 2014
Ethics expertise for health technology assessment: a Canadian national survey
Kenneth Bond, Mark Oremus, Katherine M Duthie, et al.
Pharmacoepidemiology and Drug Safety
|
January 7, 2003
A survey of physician efficacy requirements to plan clinical trials
Mark Oremus, Jean-Paul Collet, Jacques Corcos, et al.
Page
of 14